4 Cash-Heavy Biotech Stocks That Analysts Rate As Strong Buy

For some people having extra cash on hand brings a certain amount of comfort and security. For others, it seems like the cash is burning a hole in their pocket and they are eager to spend. For companies that have significant cash reserves, it is often regarded as a positive. After all, those cash reserves mean that a company has the funds on hand to make strategic moves like acquisitions, develop new markets, or hold strong during times of uncertainty. Today, we focused on the biotechnology sector to find companies with significant cash reserves. We then reduced the list to only include those that have a recent rating of 'Strong Buy' from industry analysts. We think you will be intrigued by our findings.The Current ratio is a liquidity ratio used to determine a company's financial health. The metric illustrates how easily a firm can pay back its short obligations
... Read the rest at SeekingAlpha.com